French Maritime Pine Bark — Benefits Deep Dive
The extract studied on these pages is a specific, standardized extract of the bark of the French maritime pine (Pinus pinaster), standardized to 65–75% procyanidins. That single fact shapes everything on this page. The procyanidins (chains of catechin and epicatechin, the same family of compounds found in grape seed, cocoa, and green tea) give the extract antioxidant, nitric-oxide-boosting, and anti-inflammatory activity, which is why one preparation shows up in trials for such different problems — heavy, swollen legs; aging skin; and blood pressure. The four deep-dive pages below walk through where the evidence is strongest (chronic venous insufficiency), where it is promising but smaller (skin elasticity and blood pressure), and the crucial caveat that runs through the whole literature: most pine bark extract trials are small, so the honest verdict is “plausible and often positive, but not yet proven to a high standard.”
Deep-Dive Articles
Circulation & Veins
The best-evidenced use. Chronic venous insufficiency (heavy, aching, swollen legs and varicose veins), leg edema, capillary permeability, venous ulcers, and the long-haul-flight edema and clot-prevention trials. How procyanidins are thought to seal leaky capillaries and strengthen the vein wall — and what the 2020 Cochrane review actually concluded about the quality of that evidence.
Read the deep dive →Skin Health
Skin elasticity and hydration, the trial showing increased collagen I and hyaluronic-acid-synthase gene expression, oral photoprotection against ultraviolet-induced erythema, and two studies in melasma (facial pigmentation): an open 30-woman study with no control group, and a 44-woman randomized, placebo-controlled trial alongside a triple combination cream and sunscreen, in which the Modified Melasma Area Severity Index (mMASI) score fell 49% with the extract versus 34% with placebo. Where the skin evidence is genuinely interesting and where it is still preliminary.
Read the deep dive →Blood Pressure & Heart
Endothelial function and nitric oxide, blood pressure (two meta-analyses that disagree: one pooled 12 trials and found falls of 3.22 mmHg systolic and 1.91 mmHg diastolic, the other, limited to randomized, double-blind, placebo-controlled trials, found no significant effect), platelet effects in smokers, effects on low-density lipoprotein (LDL) and cardiovascular risk factors in type 2 diabetes, and the 2012 randomized cross-over trial in coronary artery disease. Why “improves the artery lining” is better supported than “lowers blood pressure a lot.”
Read the deep dive →Standardization & Safety
Why the evidence is tied to one specific standardized extract and does not automatically transfer to other “pine bark extract” products, the doses used in trials, the good safety and tolerability record, drug interactions (blood thinners, blood-pressure drugs, surgery), and pregnancy.
Read the deep dive →Table of Contents
- Deep-Dive Articles
- What the Extract Actually Is
- Why One Extract Touches Veins, Skin, and Arteries
- Research Papers: Circulation & Veins
- Research Papers: Skin Health
- Research Papers: Blood Pressure & Heart
- Research Papers: Mechanism, Composition & Pharmacokinetics
- Research Papers: Evidence Quality, Safety & Other Uses
- External Authoritative Resources
- Connections
- Featured Videos
What the Extract Actually Is
Most trials used one standardised French maritime pine bark extract; results may not transfer to other pine bark products. It is a patented extract made from the bark of the French maritime pine, Pinus pinaster, harvested from a single managed forest — the Landes de Gascogne in southwest France. It is produced to a fixed specification: roughly 65–75% procyanidins (also called oligomeric proanthocyanidins, or OPCs), which are chains of the flavonoid building blocks catechin and epicatechin, plus smaller amounts of phenolic acids (such as ferulic and caffeic acid), taxifolin, and catechin monomers.
The word “standardized” is the key to the whole topic. Botanical extracts vary enormously from batch to batch and brand to brand. The standardized extract is manufactured to hit the same procyanidin percentage every time, and essentially all of the clinical research was done on this one extract. That is a genuine scientific strength — it is known what was actually tested — and it also means other “pine bark extract” products may not match the composition of the extract that was studied. The Standardization & Safety page explores this in depth.
Why One Extract Touches Veins, Skin, and Arteries
It can seem suspicious that a single supplement is studied for legs, faces, and hearts alike. The explanation is that all three tissues depend on the same underlying biology — small blood vessels, connective tissue, and the balance between oxidation and repair — and procyanidins act on shared control points rather than on one organ. Four proposed mechanisms recur throughout the research:
- Antioxidant free-radical scavenging. Procyanidins neutralize reactive oxygen species and help regenerate other antioxidants such as vitamin C and vitamin E. Packer and colleagues characterized this activity in detail in 1999. Oxidative stress damages vein walls, skin collagen, and the artery lining alike, so an antioxidant effect can plausibly touch all three.
- Nitric oxide and the endothelium. The extract appears to stimulate endothelial nitric oxide synthase (eNOS), increasing production of nitric oxide, the molecule that relaxes and widens blood vessels. This is the leading explanation for the endothelial and blood-pressure effects, and it also improves microcirculation in the legs and retina.
- Reduced inflammation (NF-κB). Procyanidins dampen the NF-κB inflammatory signaling pathway, lowering inflammatory mediators. This matters for the achiness of venous disease, for ultraviolet-triggered skin inflammation, and for the low-grade inflammation of metabolic disease.
- Capillary sealing and connective-tissue binding. OPCs bind to and appear to protect collagen and elastin, and they reduce capillary permeability — the tendency of small vessels to leak fluid into tissue. Less leakage means less swelling in the legs and, potentially, firmer skin.
These mechanisms are well-documented in laboratory and small human studies. The honest limitation, repeated throughout these pages, is that a plausible mechanism plus a positive small trial is not the same as proof. The 2020 Cochrane systematic review of pine bark extract included 27 randomised trials with 1,641 participants across 10 chronic disorders. Every result it reported was rated very low-certainty evidence; chronic venous insufficiency, the best-evidenced use on these pages, had only two eligible studies with 60 participants; and overall risk of bias was unclear for 22 of the 27 studies. The reviewers concluded that small sample sizes, limited numbers of trials per condition, variation in outcome measures and poor reporting mean no definitive conclusions regarding the efficacy or safety of pine bark extract supplements are possible.
Research Papers: Circulation & Veins
- Petrassi C, Mastromarino A, Spartera C (2000). Pycnogenol in chronic venous insufficiency. Phytomedicine — PubMed PMID: 11081989
- Cesarone MR et al. (2006). Comparison of Pycnogenol and Daflon in treating chronic venous insufficiency: a prospective, controlled study. Clinical and Applied Thrombosis/Hemostasis — PubMed PMID: 16708123
- Cesarone MR et al. (2010). Improvement of signs and symptoms of chronic venous insufficiency and microangiopathy with Pycnogenol: a prospective, controlled study. Phytomedicine — PubMed PMID: 20579863
- Cesarone MR et al. (2005). Prevention of edema in long flights with Pycnogenol. Clinical and Applied Thrombosis/Hemostasis — PubMed PMID: 16015414
- Belcaro G et al. (2004). Prevention of venous thrombosis and thrombophlebitis in long-haul flights with Pycnogenol. Clinical and Applied Thrombosis/Hemostasis — PubMed PMID: 15497024
- Toledo RR et al. (2017). Effect of Pycnogenol on the healing of venous ulcers. Annals of Vascular Surgery — PubMed PMID: 27521821
- Gulati OP (2014). Pycnogenol in chronic venous insufficiency and related venous disorders. Phytotherapy Research — PubMed PMID: 23775628
Research Papers: Skin Health
- Marini A et al. (2012). Pycnogenol effects on skin elasticity and hydration coincide with increased gene expressions of collagen type I and hyaluronic acid synthase in women. Skin Pharmacology and Physiology — PubMed PMID: 22270036
- Saliou C et al. (2001). Solar ultraviolet-induced erythema in human skin and NF-κB-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radical Biology and Medicine — PubMed PMID: 11163532
- Ni Z, Mu Y, Gulati O (2002). Treatment of melasma with Pycnogenol. Phytotherapy Research — PubMed PMID: 12237816
- Lima PB et al. (2021). French maritime pine bark extract (Pycnogenol) with triple combination cream for facial melasma: a double-blind, randomized, placebo-controlled trial. JEADV — PubMed PMID: 32841433
- Di Cerbo A et al. (2015). A dietary supplement improves facial photoaging and skin sebum, hydration and tonicity modulating serum fibronectin, neutrophil elastase 2, hyaluronic acid and carbonylated proteins. Journal of Photochemistry and Photobiology B. A multi-ingredient supplement (pine bark extract with collagen, coenzyme Q10, low-molecular-weight hyaluronic acid, chondroitin sulfate and glucosamine sulfate), not the extract alone. — PubMed PMID: 25732262
Research Papers: Blood Pressure & Heart
- Liu X et al. (2004). Pycnogenol, French maritime pine bark extract, improves endothelial function of hypertensive patients. Life Sciences. — PubMed PMID: 14659974
- Enseleit F et al. (2012). Effects of Pycnogenol on endothelial function in patients with stable coronary artery disease: a double-blind, randomized, placebo-controlled, cross-over study. European Heart Journal. — PubMed PMID: 22240497
- Pourmasoumi M et al. (2020). Effect of pycnogenol supplementation on blood pressure: a systematic review and meta-analysis. Phytotherapy Research. — PubMed PMID: 31637782
- Fogacci F et al. (2020). Effect of Pycnogenol on blood pressure: a PRISMA-compliant systematic review and meta-analysis. Angiology. — PubMed PMID: 31763928
- Zibadi S et al. (2008). Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutrition Research. — PubMed PMID: 19083426
- Pütter M et al. (1999). Inhibition of smoking-induced platelet aggregation by aspirin and Pycnogenol. Thrombosis Research. — PubMed PMID: 10498385
- Mohammadi S, Fulop T, Khalil A, et al. (2025). Does supplementation with pine bark extract improve cardiometabolic risk factors? A systematic review and meta-analysis. BMC Complementary Medicine and Therapies. — PubMed PMID: 39987124
What the blood-pressure meta-analyses found. The 2020 meta-analysis by Pourmasoumi and colleagues pooled 12 clinical trials (922 participants) and found that the extract lowered systolic blood pressure by 3.22 mmHg and diastolic blood pressure by 1.91 mmHg. The 2020 meta-analysis by Fogacci and colleagues, limited to randomized, double-blind, placebo-controlled trials (7 trials, 626 participants), found no significant effect on systolic or diastolic blood pressure. A 2025 meta-analysis of 27 randomized controlled trials (1,685 participants) found that pine bark extract lowered systolic blood pressure by 2.26 mmHg, diastolic blood pressure by 2.62 mmHg, fasting blood sugar by 6.25 mg/dL, hemoglobin A1c (HbA1c) by 0.32%, body weight by 1.37 kg and LDL cholesterol by 5.07 mg/dL, with no significant effect on waist-to-hip ratio, body mass index, waist circumference, insulin, high-density lipoprotein (HDL) cholesterol, triglycerides or total cholesterol; its authors call for further high-quality trials with larger samples and longer durations.
Research Papers: Mechanism, Composition & Pharmacokinetics
- Packer L, Rimbach G, Virgili F (1999). Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radical Biology and Medicine. — PubMed PMID: 10490291
- Rohdewald P (2002). A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. International Journal of Clinical Pharmacology and Therapeutics. — PubMed PMID: 11996210
- Maimoona A et al. (2011). A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. Journal of Ethnopharmacology. — PubMed PMID: 21044675
- Grimm T et al. (2006). Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers. BMC Clinical Pharmacology. — PubMed PMID: 16887024
- Fitzpatrick DF, Bing B, Rohdewald P (1998). Endothelium-dependent vascular effects of Pycnogenol. Journal of Cardiovascular Pharmacology. — PubMed PMID: 9781917
Research Papers: Evidence Quality, Safety & Other Uses
- Robertson NU et al. (2020). Pine bark (Pinus spp.) extract for treating chronic disorders. Cochrane Database of Systematic Reviews. — PubMed PMID: 32990945
- Schoonees A et al. (2012). Pycnogenol (extract of French maritime pine bark) for the treatment of chronic disorders. Cochrane Database of Systematic Reviews. — PubMed PMID: 22513958
- Belcaro G et al. (2008). Variations in C-reactive protein, plasma free radicals and fibrinogen values in patients with osteoarthritis treated with Pycnogenol. Redox Report. — PubMed PMID: 19017467
- Lau BH et al. (2004). Pycnogenol as an adjunct in the management of childhood asthma. Journal of Asthma. — PubMed PMID: 15641632
- Schönlau F, Rohdewald P (2001). Pycnogenol for diabetic retinopathy: a review. International Ophthalmology. — PubMed PMID: 12498513
- Tian Y, Zhou Q, Li W, Liu M, Li Q, Chen Q (2023). Efficacy of L-arginine and Pycnogenol® in the treatment of male erectile dysfunction: a systematic review and meta-analysis. Frontiers in Endocrinology. — PubMed PMID: 37908749
Erectile dysfunction. A 2023 meta-analysis of 3 studies (184 patients) of pine bark extract combined with L-arginine found better erectile-function, intercourse-satisfaction, orgasmic-function, overall-satisfaction and sexual-desire scores than in the control groups, with no significant difference in testosterone levels. The authors describe a possible benefit in mild to moderate erectile dysfunction and state that more randomized controlled trials are needed.
External Authoritative Resources
- Cochrane Review (Robertson et al., 2020) — Pine bark extract for chronic disorders — the most rigorous independent assessment of the overall evidence; conclusions are cautious
- Drugs.com — French maritime pine bark extract (Professional Natural Products monograph) — uses, dosing, interactions, and safety
- PubMed — all research on the standardized extract
Connections
- Pine Bark for Circulation & Veins
- Pine Bark for Skin Health
- Pine Bark for Blood Pressure & Heart
- Pine Bark: Standardization & Safety
- French Maritime Pine Bark (Main Page)
- Grape Seed Extract (related OPCs)
- Resveratrol
- Quercetin
- Arginine (nitric oxide)
- Vitamin C
- Varicose Veins
- Hypertension
- Type 2 Diabetes
- Diabetic Retinopathy
- Melasma
- All Antioxidants